Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosa to transducing bacteriophages

FEMS Immunology and Medical Microbiology

Volumn 28, Issue 4, 2000, Pages 307-312

  Nzula, Sazini ^a   Vandamme, Peter ^b   Govan, John R W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Bacteriophage; Burkholderia cepacia; Genomovar; Pseudomonas aeruginosa; Transduction

Indexed keywords

ARTICLE; BACTERIOPHAGE; BURKHOLDERIA CEPACIA; GENETIC TRANSDUCTION; GENOME; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

BACTERIOPHAGES; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; HUMANS; LYSOGENY; MICROSCOPY, ELECTRON; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PHAGES; TRANSDUCTION, GENETIC;

EID: 0034048510     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(00)00171-1     Document Type: Article

References (32)

1. Burkholder W.H. Sour skin, a bacterial rot of onion bulbs. Phytopathology. 40:1950;115-117.
2. Stanier R.Y., Palleroni N.J., Doudoroff M. The aerobic pseudomonads: a taxonomic study. J. Gen. Microbiol. 43:1966;159-271.
3. Beckman W., Lessie T.G. Response of Pseudomonas cepacia to β-lactam antibiotics: utilisation of penicillin G as the carbon source. J. Bacteriol. 140:1979;1126-1128.
4. Koenig D.W., Pierson D.L. Microbiology of the space shuttle water systems. Water Sci. Technol. 35:1997;59-64.
5. Rosenberg, F.A. (1999) Burkholderia cepacia and bottled water. ASM News December, 793-794.
6. Govan J.R.W., Hughes J.E., Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:1996;395-407.
7. Holmes A., Nolan R., Taylor R., Finley P.R., Riley M., Jiang R.Z., Steinbach S., Goldstein R. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J. Infect. Dis. 179:1999;1197-1205.
8. Yabuuchi E., Kosako Y., Oyaizu H. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol. Immunol. 36:1992;1251-1275.
9. Vandamme P., Holmes A., Vancanneyt M., Coenye T., Coopman R., Revets H., Lauwers S., Gillis M., Kersters K., Govan J.R.W. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans species. Int. J. Syst. Bacteriol. 47:1997;1200.
10. Vandamme P., Mahenthiralingam E., Holmes B., Coenye T., Hoste B., De Vos P., Henry D., Speert D.P. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). J. Clin. Microbiol. 38:2000;1042-1047.
11. Holmes A., Govan J.R.W., Goldstein R. Agricultural use of Burkholderia (Pseudomonas) cepacia: A threat to human health? Emerg. Infect. Dis. 4:1998;221-227.
12. Li Puma J.J., Mahenthiralingam E. Commercial use of Burkholderia cepacia: Are there additional threats? Emerg. Infect. Dis. 5:1998;5-6.
13. Vidaver A.K., Doyle M.P., Gerone P.J., Gonzalez C.F., Hall P., Hunter Cevera J.C., Loria R., Newsome R.L., Shore S.H., Wilkins T. Burkholderia cepacia - friend or foe? ASM News. 65:1999;587.
14. Govan J.R.W., Balindreau J., Vandamme P. Burkholderia cepacia - friend and foe. ASM News. 66:2000;124-125.
15. King E.B., Parke J.L. Biocontrol of Aphanomyces root rot and Pythium damping-off by Pseudomonas cepacia AMMD on four pea cultivars. Plant Dis. 77:1993;1185-1188.
16. Mahenthiralingam E., Coenye T., Chung J., Speert D.P., Govan J.R.W., Taylor P., Vandamme P. A diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J. Clin. Microbiol. 38:2000;910-913.
17. Matsumoto H., Itoh Y., Ohta S., Terawaki Y. A generalized transducing phage of Pseudomonas cepacia. J. Gen. Microbiol. 132:1986;2583-2586.
18. Butler S.L., Doherty C.J., Hughes J.E., Nelson J.W., Govan J.R.W. Burkholderia cepacia and cystic fibrosis - Do natural environments present a potential hazard? J. Clin. Microbiol. 33:1995;1001-1004.
19. Cheng K., Smyth R.L., Govan J.R.W., Doherty C., Winstanley C., Denning N., Heaf D.P., vanSaene H., Hart C.A. Spread of a β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet. 348:1996;639-642.
20. Govan J.R.W., Brown P.H., Maddison J., Doherty C., Nelson J.W., Dodd M., Greening A., Webb A.K. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 342:1993;15-19.
21. Krishnapillai V. A novel transducing phage. Its role in recognition of possible new host-controlled modification system in Pseudomonas aeruginosa. Mol. Gen. Genet. 114:1971;134-143.
22. Westphal O., Luderitz O. Chemische Erforschung von Lipopolysacchariden gramnegativer Bakterien. Angew. Chem. 66:1954;407-417.
23. Hancock, I.C. and Poxton, I.R. (Eds.) (1988) Bacterial Cell Surface Techniques. Vol. 4, Separation and Purification of Surface Components, pp. 90-92. John Wiley and Sons, Chichester.
24. Govan J.R.W. Studies on the pyocins of Pseudomonas aeruginosa: morphology and mode of action of contractile pyocins. J. Gen. Microbiol. 80:1974;1-15.
25. Holloway, B.W., Krishnapillai, V., Clarke, P.H. and Richmond, M.H. (Eds.) (1975) Genetics and Biochemistry of Pseudomonas. Bacteriophages and bacteriocins, pp. 99-132. John Wiley and Sons, London.
26. Parker C., Richardson S.H., Romig W.R. Production of bacteriophage-associated materials by Vibrio cholarae: possible correlation with pathogenicity. Infect. Immun. 1:1970;417-420.
27. Kapur V., Nelson K., Schlievert P.M., Selander R.K., Musser J.M. Molecular population genetic evidence of horizontal spread of two alleles of the pyrogenic exotoxic C gene (SpeC) among pathogenic clones of Streptococcus pyogenes. Infect. Immun. 60:1992;3517.
28. Mooi F.R., Bik E.M. The evolution of epidemic Vibrio cholerae strains. Trends Microbiol. 5:1997;161-165.
29. Lessie T.G., Hendrickson W., Manning B.D., Devereux R. Genomic complexity and plasticity of Burkholderia cepacia. FEMS Microbiol. Lett. 144:1996;117-128.
30. Mack K., Titball R.W. The detection of insertion sequences within the human pathogen Burkholderia pseudomallei which have been identified previously in Burkholderia cepacia. FEMS Microbiol. Lett. 162:1998;69-74.
31. Nelson J.W., Butler S.L., Brown P.H., Greening A., Govan J.R.W. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis. J. Med. Microbiol. 39:1993;39-47.
32. Evans E., Poxton I.R., Govan J.R.W. Lipopolysaccharide chemotypes of Burkholderia cepacia. J. Med. Microbiol. 48:1999;825-832.